Klarna Partners with Coinbase to Expand Stablecoin Funding Options Swedish fintech giant Klarna, renowned for its “Buy Now, Pay Later” services, has initiated aKlarna Partners with Coinbase to Expand Stablecoin Funding Options Swedish fintech giant Klarna, renowned for its “Buy Now, Pay Later” services, has initiated a

Klarna Joins Coinbase to Boost USDC Funding from Major Institutions

For feedback or concerns regarding this content, please contact us at [email protected]
Klarna Joins Coinbase To Boost Usdc Funding From Major Institutions

Klarna Partners with Coinbase to Expand Stablecoin Funding Options

Swedish fintech giant Klarna, renowned for its “Buy Now, Pay Later” services, has initiated a strategic partnership with cryptocurrency exchange Coinbase to incorporate stablecoins into its short-term funding mechanisms. This move signifies a notable advancement in institutional engagement with digital assets, further integrating cryptocurrencies into mainstream financial operations.

Key Takeaways

  • Klarna plans to raise short-term funding through USDC with support from Coinbase’s infrastructure.
  • CEO Niclas Neglén highlights stablecoin’s potential to diversify funding sources and connect with new investors.
  • The initiative complements Klarna’s existing funding channels, including consumer deposits and debt instruments.
  • The project remains in development, with regulatory and operational risks acknowledged.

Tickers mentioned: No specific stock tickers are referenced in this context.

Sentiment: Neutral

Price impact: Neutral. The announcement reflects progress in institutional adoption without immediate market repercussions.

Market context: As traditional finance intersects with cryptocurrency, fintech firms increasingly leverage digital assets for flexible funding strategies amidst evolving regulatory landscapes.

Klarna’s Crypto Strategy expands

Klarna disclosed that its stablecoin funding initiative is still under development and remains separate from its broader plans to integrate cryptocurrencies into consumer and merchant services. The company envisions future offerings such as digital wallets and additional blockchain-based financial products by 2026, aiming to deepen its presence in the digital asset ecosystem.

The firm emphasizes caution, noting that the project is subject to regulatory, market, and operational risks that could impact its outcomes. The selection of Coinbase was driven by its extensive experience providing infrastructure for large enterprises, including custody, settlement, and blockchain financial services, making it a natural partner for Klarna’s ambitions.

Klarna Unveils Dollar-Backed Stablecoin

Last month, Klarna launched a US dollar-pegged stablecoin, KlarnaUSD, becoming the first digital bank to issue a token on Stripe and Paradigm’s Tempo blockchain, a layer-1 platform. Currently in testing on Tempo’s testnet, a full mainnet rollout is slated for 2026, according to the company. This move expands Klarna’s longstanding partnership with Stripe, combining traditional banking with innovative blockchain infrastructure.

Built by Stripe-owned Bridge, KlarnaUSD represents a significant step toward integrating stablecoins into mainstream payments. The issuance aligns with recent regulatory developments, notably the US GENIUS Act, which aims to standardize stablecoin regulations and spur issuance efforts across the industry.

This article was originally published as Klarna Joins Coinbase to Boost USDC Funding from Major Institutions on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.

Market Opportunity
USDCoin Logo
USDCoin Price(USDC)
$1.0001
$1.0001$1.0001
+0.02%
USD
USDCoin (USDC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09